How is response to TKI therapy monitored in chronic myelogenous leukemia (CML)?

Updated: Oct 23, 2019
  • Author: Rossa Khalaf, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Answer

Response to TKI is usually monitored by measurement of hematologic, cytogenetic, and molecular responses. [26, 27, 28]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!